Education, Science, Technology, Innovation and Life
Open Access
Sign In

Injection of New PMMA* Loaded Microspheres into Anterior Chamber to Establish a Rabbit Glaucoma Model

Download as PDF

DOI: 10.23977/medsc.2023.040213 | Downloads: 17 | Views: 463

Author(s)

Shen Meitong 1, Koole Levinus Hendrik 2

Affiliation(s)

1 School of Ophthalmology and Optometry (School of Biomedical Engineering), Wenzhou Medical University, Wenzhou, 325007, China
2 Eye Hospital of Wenzhou Medical University, Wenzhou, 325007, China

Corresponding Author

Koole Levinus Hendrik

ABSTRACT

Objective: To develop a novel PMMA material microsphere and characterize it. Named it PMMA*.The microsphere was loaded with drugs, and the intraocular pressure of rabbits was increased by anterior chamber injection, so as to establish a new animal model of ocular hypertension. Methods: PMMA* microspheres with a diameter of 50-80μm were prepared, and the drug loading, release and biosafety of PMMA* microspheres were analyzed. PMMA* microsphere suspension was prepared at 1% dosage of atropine sulfate. Eighteen healthy male New Zealand white rabbits were selected, with the right eye as the experimental eye and the left eye as the control eye. They were randomly divided into blank microsphere group, atropine sulfate group and atropine sulfate loaded microsphere group with 6 rabbits in each group. The chronic ocular hypertension model of the right eye was established. Intraocular pressure was monitored postoperatively and Micro-CT was used to determine the position of the microsphere at the anterior chamber Angle. The pathological changes of chronic glaucoma were studied. Results: PMMA* microspheres have the characteristics of micropore structure, adjustable size, slow release, in situ residence and good biosafety. There was no significant difference in preoperative intraocular pressure in rabbits (P>0.05), which was comparable. At 15 days after surgery, the intraocular pressure in experimental eyes was significantly higher than that in control eyes, with statistical significance (P<0.05), and the increase of intraocular pressure caused by drug-loaded PMMA* microspheres was more significant. Micro-CT determined the position of the microsphere in the anterior chamber Angle of rabbit. The atropine sulfate loaded microspheres showed more obvious ganglion cell - retinal nerve fiber layer damage. Conclusions:The PMMA* microspheres synthesized in this study have good drug loading performance and slow release performance. Intraventral injection of drug-loaded PMMA* microspheres can block the outflow of aqueous solution to establish a better chronic glaucoma model.

KEYWORDS

Glaucoma; PMMA*; Hydrogel; Glaucoma model; Anterior chamber injection

CITE THIS PAPER

Shen Meitong, Koole Levinus Hendrik, Injection of New PMMA* Loaded Microspheres into Anterior Chamber to Establish a Rabbit Glaucoma Model. MEDS Clinical Medicine (2023) Vol. 4: 83-99. DOI: http://dx.doi.org/10.23977/medsc.2023.040213.

REFERENCES

[1] Jonas J.B., et al., Glaucoma [J]. The Lancet, 2017. 390(10108): p. 2183-2193.
[2] Ishikawa M., et al., Experimentally Induced Mammalian Models of Glaucoma [J]. Biomed Res Int, 2015. 2015: p. 281214.
[3] Xie M.S., et al., Experimental circumferential canaloplasty with a new Schlemm canal microcatheter [J]. Int J Ophthalmol, 2018. 11(1): p. 1-5.
[4] Scott H. Greenstein, M.D., David H. et al., Systemic Atropine and Glaucoma [J], 1984, Vol. 60, No. 10.
[5] Tawakoli P.N., et al., Comparison of different live/dead stainings for detection and quantification of adherent microorganisms in the initial oral biofilm [J]. Clin Oral Investig, 2013. 17(3): p. 841-50.
[6] Deshpande G., et al., Structural evaluation of preperimetric and perimetric glaucoma. Indian[J]. Ophthalmol, 2019. 67(11): p. 1843-1849.
[7] Clark D.P. and C.T. Badea, Advances in micro-CT imaging of small animals [J]. Phys Med, 2021. 88: p. 175-192.
[8] Gellrich M.M., The slit lamp as videography console: Video article[J]. Ophthalmologe, 2018. 115(10): p. 885-892.
[9] Hu X., et al., Interplay between Muller cells and microglia aggravates retinal inflammatory response in experimental glaucoma. [J]. Neuroinflammation, 2021. 18(1): p. 303.
[10] Mohan N., et al., Newer advances in medical management of glaucoma. Indian [J]. Ophthalmol, 2022. 70(6): p. 1920-1930.
[11] Manuel González de la Rosa, Glaucoma crónico de ángulo abierto [J]. Med Clin (Barc).2005;124(12):461-6.
[12] Kang I.G., et al., Hydroxyapatite Microspheres as an Additive to Enhance Radiopacity, Biocompatibility, and Osteoconductivity of Poly(methyl methacrylate) Bone Cement[J]. Materials (Basel), 2018. 11(2).
[13] van Zyl T., et al., Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis [J]. Proc Natl Acad Sci U S A, 2020. 117(19): p. 10339-10349.
[14] Pang I.H. and A.F. Clark, Inducible rodent models of glaucoma [J]. Prog Retin Eye Res, 2020. 75: p. 100799.
[15] Yun H, Lathrop KL, Yang E, et al. Angle Closure Glaucoma Precipitated by Aerosolized Atropine.[J].PLoS One, 2014, 9(9): e107446.
[16] Urbonaviciute D., D. Buteikiene and I. Januleviciene, A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment. [J]. Medicina (Kaunas), 2022. 58(12).
[17] Jiang S., M. Kametani, D.F. Chen, Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy. [J]. Front Immunol, 2020. 11: p. 65.
[18] Bell K., et al., Modulation of the Immune System for the Treatment of Glaucoma. [J]. Current Neuropharmacology, 2018. 16(7): p. 942-958.
[19] Auler N., et al., Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways. [J]. Biology (Basel), 2021. 10(12).
[20] Gionfriddo J.R., et al., Alpha-Luminol prevents decreases in glutamate, glutathione, and glutamine synthetase in the retinas of glaucomatous DBA/2J mice. [J]. Vet Ophthalmol, 2009. 12(5): p. 325-32. 

Downloads: 4578
Visits: 198460

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.